According to Retractable Technologies's latest financial reports the company's current revenue (TTM) is $43.59 M. In 2022 the company made a revenue of $94.81 M a decrease over the years 2021 revenue that were of $0.18 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $43.59 M | -54.02% |
2022 | $94.81 M | -49.67% |
2021 | $0.18 B | 130.12% |
2020 | $81.86 M | 95.86% |
2019 | $41.79 M | 25.61% |
2018 | $33.27 M | -3.53% |
2017 | $34.49 M | 15.65% |
2016 | $29.82 M | 0.93% |
2015 | $29.55 M | -14.39% |
2014 | $34.52 M | 12.13% |
2013 | $30.78 M | -8.5% |
2012 | $33.64 M | 4.8% |
2011 | $32.1 M | -11.37% |
2010 | $36.21 M | -7.09% |
2009 | $38.98 M | 39.72% |
2008 | $27.89 M | 6.12% |
2007 | $26.28 M | 3.81% |
2006 | $25.32 M | 4.5% |
2005 | $24.23 M | 12.61% |
2004 | $21.52 M | 12.81% |
2003 | $19.07 M | -6.09% |
2002 | $20.31 M | 25.83% |
2001 | $16.14 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | $19.49 B | 44,609.57% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | $0.74 B | 1,615.07% | ๐บ๐ธ USA |
ICU Medical
ICUI | $2.25 B | 5,081.85% | ๐บ๐ธ USA |
Antares Pharma ATRS | $0.18 B | 322.01% | ๐บ๐ธ USA |
Insulet PODD | $1.69 B | 3,792.71% | ๐บ๐ธ USA |